Patent ID: 8741333

Claim:
A formulation for treating dermatitis or psoriasis, comprising: a) triamcinolone acetonide; b) a solvent vehicle, comprising: i) a volatile solvent system including ethanol, and ii) a non-volatile solvent system including propylene glycol, wherein the non-volatile solvent system facilitates the delivery of the triamcinolone acetonide at therapeutically effective rates; and c) a solidifying agent; wherein the formulation has a viscosity suitable for application and adhesion to a skin surface prior to evaporation of the volatile solvent system, the formulation upon being applied to a skin surface as a layer forms a solidified layer after at least partial evaporation of the volatile solvent system, and the triamcinolone acetonide is dermally deliverable at the therapeutically effective rate after the volatile solvent system is evaporated.